White Paper

The Benefits Of End-To-End Formulation And Fill/Finish Of Biologics

Source: Curia

By Tyler Jones, PhD, Director, Formulation, and Geno Worke, Head of Manufacturing, Curia


Due to their delicate nature and sensitivity to various processes, proper formulation development is crucial for biologics. Review the challenges of transitioning a promising drug candidate from initial formulation stages to full-scale manufacturing.

The success of manufacturing hinges on a strong link between formulation development and manufacturability where early formulation decisions can significantly impact future production. A well-defined biologic drug product requires a deep understanding of the molecule's properties and its critical quality attributes. Effective formulation development must consider potential impurities that can affect the final formulation.

Close collaboration between formulation development and clinical fill/finish teams fosters smooth technology transfers, minimizes problems, and leads to faster development with improved quality and safety.

Dive deeper into the importance of understanding and managing impurities in drug formulations. Explore a case study that demonstrates how metal contaminants introduced during manufacturing can accelerate oxidation and how this was successfully mitigated. Learn more about the tech transfer process in pharmaceutical manufacturing, focusing on factors such as solubility, material compatibility, and product concentration.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online